Welcome
The Tara Miller Melanoma Center at the Abramson Cancer Center of the University of Pennsylvania is a comprehensive center that unites research, clinical care, education, and outreach programs to improve the lives of patients with melanoma. Despite tremendous advances in melanoma therapy, current therapies do not cure every patient. Many patients are still suffering and dying from melanoma. The Tara Miller Melanoma Center is dedicated to overcoming this challenge.
We are committed to providing exceptional care to all of our patients with melanoma and other types of skin cancers. Using a multidisciplinary approach, we deliver personalized care, integrating and connecting with providers from Dermatology, Medical Oncology, Surgical Oncology, Radiation Oncology, and Pathology. We also collaborate with basic, translational, and population scientists who study new ways to prevent, diagnose, and treat melanoma. The Center supports innovative research to truly change the trajectory of the disease for an individual patient. The Tara Miller Melanoma Center is a place where patients and their families can turn to for education and find up to date information regarding the best treatments for melanoma.
The Tara Miller Melanoma Center was established in 2019 with generous support from Debbie and George Miller in honor of their daughter, Tara Miller. As Dr. Bob Vonderheide, the Director of the Abramson Cancer Center said, “The number of people who were moved by Tara’s courage and her character is second only the number of lives that will be forever changed by her legacy”.
New Treatment Option Offered In TMMC
Tumor Infiltrating Lymphocyte (TIL) Therapy
TIL therapy is a type of immunotherapy that uses your body's own T cells (lymphocytes) to find and eliminate cancer cells. This new treatment is now available at Penn for eligible patients with advanced/metastatic melanoma that has not responded to other immunotherapy or targeted therapy treatments. To schedule an appointment with our Penn melanoma care team for evaluation, please contact: 215-615-5858.